Search results for "METASTASIS"

showing 10 items of 986 documents

Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicente…

2006

This study was designed to evaluate the efficacy and safety of irinotecan/cetuximab administered as third- or fourth-line therapy in a retrospective series of patients with metastatic colorectal cancer refractory to oxaliplatin and irinotecan. Patients and Methods: Most patients (90%) had been previously treated with adjuvant 5-fluorouracil/leucovorin, and all had received oxaliplatin-based regimens before receiving irinotecan- based second-line treatment. Sixty patients with irinotecan-refractory colorectal cancer received a regimen comprising weekly irinotecan 120 mg/m 2 as a 1-hour intravenous infusion and cetuximab 400 mg/m 2 infused over 2 hours as the initial dose and 250 mg/m 2 infus…

AdultMaleOncologymedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsSettore MED/06 - Oncologia MedicaColorectal cancermedicine.medical_treatmentCetuximabAdenocarcinomaAntibodies Monoclonal HumanizedIrinotecanDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisSurvival analysisAgedAged 80 and overChemotherapyCetuximabPerformance statusbusiness.industryGastroenterologyAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival Analysisdigestive system diseasesOxaliplatinErbB ReceptorsIrinotecanSettore MED/18 - Chirurgia GeneraleRegimenOncologyCamptothecinFemaleEpidermal growth factor receptor Oxaliplatin Vascular endothelial growth factorColorectal Neoplasmsbusinessmedicine.drugClinical Colorectal Cancer
researchProduct

Metastatic carcinoma of the oral region: An analysis of 21 cases

2017

Background Metastatic carcinoma to the jaws and oral region are very rare, representing less than 1% of all oral tumors. Unfortunately, oral metastasis is usually manifestation of an advanced stage of primary cancer, and indicates widespread disease and poor prognosis. Material and Methods In this retrospective study, a total of 2039 patients with history of oral malignant tumor between 1980 and 2012 at Seoul National University Dental Hospital were evaluated. We analyzed the dental and medical records, and histopathological database of 2039 patients to assess the prevalence of oral metastasis of carcinoma in terms of sex and age, as well as, the most common origin of primary cancer, and pr…

AdultMaleOncologymedicine.medical_specialtyMetastatic carcinomaMetastasis03 medical and health sciences0302 clinical medicineInternal medicineBiopsymedicineCarcinomaHumansGeneral DentistryAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryResearchMedical recordRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisHepatocellular carcinomaUNESCO::CIENCIAS MÉDICASAdenocarcinomaFemaleMouth NeoplasmsSurgeryRadiologyOral SurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Methotrexate, Vinblastine, Epidoxorubicin, and Bleomycin as Second-Line Chemotherapy for Recurrent and/or Metastatic Squamous Cell Carcinoma of the H…

1994

Thirty evaluable patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck region previously treated with cisplatin-based chemotherapy were treated with a combination of methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy. Besides surgery and/or radiotherapy all patients had previously received chemotherapy as induction therapy or as palliation for recurrent disease. Only 20% of patients achieved a partial objective response with a mean duration of 5.6 months (range 3.2-6.2), and 30% of patients had a stabilization of disease with a mean duration of 4.2+ months (range 3.8-6.0). Patients who responded had rhinopharyngeal carcinoma…

AdultMaleOncologymedicine.medical_specialtyVomitingmedicine.medical_treatmentVinblastineBleomycinSecond line chemotherapyMetastasisBleomycinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansBasal cellHead and neckAgedEpirubicinCisplatinStomatitisChemotherapybusiness.industryPalliative CareRemission InductionHead and neck cancerLeukopeniaMiddle Agedmedicine.diseaseCombined Modality TherapySurvival RateMethotrexateOtorhinolaryngologychemistryHead and Neck NeoplasmsCarcinoma Squamous CellFemaleFluorouracilCisplatinNeoplasm Recurrence Localbusinessmedicine.drugORL
researchProduct

The significance of a uniform definition of pathological lymph nodes in Hodgkin lymphoma: impact of different thresholds for positive lymph nodes in …

2007

Abstract Background and Purpose The most commonly used approach for the assessment for differentiating malignant versus reactive lymph nodes is the measurement of the cross-section diameter of the lymph nodes in the transversal CT-planes. The intention of this article is to assess the impact of varying definitions of pathological lymph node size in CT-imaging in patients with Hodgkin lymphoma and to evaluate its effect on staging, chemotherapy regimes and radiation field size. Materials and methods Pretherapeutic CT-scans of 10 consecutive patients with Hodgkin lymphoma have been evaluated based on two different definitions for malignant lymph node size; the classification of the German stu…

AdultMalePathologymedicine.medical_specialtyAdolescentLymph node regionsmedicine.medical_treatmentSensitivity and Specificity030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineRisk FactorsMedicineHumansRadiology Nuclear Medicine and imagingLymph nodePathologicalAgedNeoplasm Stagingbusiness.industryRadiation fieldHematologyMiddle AgedCombined Modality TherapyHodgkin Disease3. Good healthRadiation therapymedicine.anatomical_structureOncology030220 oncology & carcinogenesisLymphatic MetastasisHodgkin lymphomaFemaleLymphRadiologyLymph NodesCt imagingbusinessTomography X-Ray ComputedRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

ANO1 as a marker of oral squamous cell carcinoma and silencing ANO1 suppresses migration of human scc-25 cells

2013

Objectives: The purpose of this study is to confirm that ANO1 correlates with occurrence and metastasis of OSCC. Study Design: Immunohistochemistry was used to detect the expression of ANO1 in 160 specimens of OSCC and normal tissues. Lentiviral silencing ANO1 was used in scc-25 cell line to study the cell migration and cell detachment. Results: Immunohistochemical staining revealed that ANO1 was expressed in a large majority (132 out of 160, 82.5%) of OSCC specimens and that the rate of ANO1 expression in OSCC was significantly higher than that of normal tissue ( P 0.05). Conclusions: Our study shows that abnormal expression of ANO1 correlated with the occurrence and metastasis of OSCC in …

AdultMalePathologymedicine.medical_specialtyCellOdontologíaBiologyMetastasisCell MovementChloride ChannelsBiomarkers TumorTumor Cells CulturedCarcinomamedicineHumansGene silencingGene SilencingGeneral DentistryAnoctamin-1Chloride channel activityMouth neoplasmOral Medicine and PathologyResearchCell migrationMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludNeoplasm Proteinsstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellImmunohistochemistryFemaleMouth NeoplasmsSurgeryMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Lymphadenomatous carcinoma of the sublingual gland: report of a first case in an unusual localization.

2008

Background. Lymphadenomatous carcinoma of the salivary gland is a very rare tumor, which hitherto occurred exclusively in the parotid gland. This report describes a case of lymphadenomatous carcinoma of the sublingual gland, which is thought to be the first report of this special entity. Methods and Results. A 36-year-old man was seen with slowly growing mass on his right floor of mouth. Upon surgical removal, the mass was well encapsulated. Microscopic exami- nation revealed a biphasic appearance with islands of neoplas- tic epithelial cells presenting against a dense lymphoid stroma, while the epithelial compartment showed features of malig- nancy. During 30-months of close follow-up, the…

AdultMalePathologymedicine.medical_specialtyFloor of mouthSalivary glandbusiness.industrySublingual glandCancerSublingual Gland NeoplasmsAnatomymedicine.diseaseAdenolymphomaCarcinoma Adenoid CysticMetastasisParotid glandLesionmedicine.anatomical_structureTreatment OutcomeOtorhinolaryngologymedicineCarcinomaHumansmedicine.symptombusinessHeadneck
researchProduct

Testicular fusocellular rhabdomyosarcoma as a metastasis of elbow sclerosing rhabdomyosarcoma: A clinicopathologic, immunohistochemical and molecular…

2010

Abstract Sclerosing rhabdomyosarcoma (SRMS) is an infrequent variant of rhabdomyosarcoma characterized by extensive intercellular hyaline fibrosis. We report the case of a 37 year-old male with a 9 × 6 cm SRMS on the right elbow. Histologically, the tumor showed an abundant extracellular hyaline matrix with extratumoral vascular emboli and microscopic foci of fusocellular embryonal rhabdomyosarcoma (FRMS) separated by a fibrotic band from the sclerosing areas. One year later the patient presented with a right intratesticular tumor of 1.2 × 0.8 cm, which was reported as pure FRMS. Immunohistochemically, SRMS was positive only for MyoD1 and Vimentin and negative for Myogenin and Desmin. Both …

AdultMalePathologymedicine.medical_specialtyHistologyTime FactorsVimentinCase ReportSoft Tissue NeoplasmsSclerosing rhabdomyosarcomaBiologyTranslocation GeneticPathology and Forensic MedicineMetastasisFatal OutcomeTesticular Neoplasmslcsh:PathologymedicineBiomarkers TumorElbowHumansRhabdomyosarcoma EmbryonalWhole Body ImagingRhabdomyosarcomaHyalineIn Situ Hybridization FluorescenceSclerosisChromosomes Human Pair 13Forkhead Box Protein O1MediastinumForkhead Transcription FactorsGeneral Medicinemedicine.diseasemusculoskeletal systemFibrosisImmunohistochemistrymedicine.anatomical_structureTreatment OutcomeChemotherapy Adjuvantbiology.proteinDesminEmbryonal rhabdomyosarcomaTomography X-Ray ComputedOrchiectomylcsh:RB1-214
researchProduct

Contrast-Enhanced Ultrasonography With SonoVue

2009

Objective. We investigated the ability of contrast-enhanced ultrasonography with SonoVue (Bracco SpA, Milan, Italy), a sulfur hexafluoride microbubble contrast agent, to reveal differences between benign and malignant focal splenic lesions. Methods. In a prospective study we investigated 35 lesions in 35 patients (24 male and 11 female; mean age ± SD, 54 ± 15 years) with focal splenic lesions detected by B-mode ultrasonography. After intravenous injection of 1.2 to 2.4 mL of SonoVue, the spleen was examined continuously for 3 minutes using low–mechanical index ultrasonography with contrastspecific software. The final diagnosis was established by histologic examination, computed tomography, …

AdultMalePathologymedicine.medical_specialtyLymphomaSulfur HexafluorideContrast MediaSensitivity and SpecificityMetastasisHemangiomaLesionHematomamedicineHumansRadiology Nuclear Medicine and imagingCystAbscessPhospholipidsUltrasonographyRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industrySplenic NeoplasmsReproducibility of ResultsEchogenicityMagnetic resonance imagingImage Enhancementmedicine.diseaseFemalemedicine.symptombusinessJournal of Ultrasound in Medicine
researchProduct

CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.

2007

A role for CXCR3, the receptor for chemokines Mig, IP-10 and interferon-inducible T cell alpha-chemoattractant, in tumour cell migration during melanoma progression has been proposed.To analyse CXCR3 expression in primary cutaneous malignant melanomas and its comparison with clinicopathological and prognostic factors.A retrospective immunohistochemical study was carried out on formalin-fixed paraffin-wax-embedded sections from 82 patients with primary invasive cutaneous melanomas, with a monoclonal antibody to CXCR3 (clone 49801.111; RD Systems). Immunoreactivity was semiquantitatively evaluated: labelling intensity (0, absent; 1, weak; 2, moderate; 3, strong) multiplied by the percentage o…

AdultMalePathologymedicine.medical_specialtyReceptors CXCR3Skin NeoplasmsCXCR3Pathology and Forensic MedicineImmunoenzyme TechniquesmedicineBiomarkers TumorHumansNeoplasm InvasivenessLymph nodeMelanomaAgedRetrospective StudiesAged 80 and overUnivariate analysisbusiness.industryMelanomaGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurvival AnalysisNeoplasm Proteinsmedicine.anatomical_structureLymphatic MetastasisCutaneous melanomaDisease ProgressionImmunohistochemistryFemaleReceptors ChemokineOriginal ArticleSkin cancerbusinessImmunostainingJournal of clinical pathology
researchProduct

Conservative Surgery of Renal Carcinoma: The EIRSS Experience

1981

Summary— Seventy-two patients with renal carcinoma (RC) in a solitary kidney or bilateral synchronous tumours underwent parenchyma-sparing excision of their neoplasms. This was performed in situin 51 and extracorporeally in 21 kidneys, with a complication rate respectively of 1 7 and 43%. The 5-year survival rates were 78% for unilateral disease, 48% for bilateral synchronous and 38% for bilateral asynchronous disease. Survival correlated with Pcategory, grade and diameter of the tumour. Vascular invasion and spindle cells indicated a poor prognosis; the position of the tumour, oncocytic elements, calcification, lymphocytic infiltration or the predominance of clear cell or granular cells di…

AdultMalePoor prognosismedicine.medical_specialtyUrologySolitary kidneyUnilateral diseasePostoperative ComplicationsHumansMedicineComplication rateNeoplasm MetastasisAgedLymphocytic infiltrationbusiness.industryMiddle AgedPrognosismedicine.diseaseKidney NeoplasmsSurgeryCreatinineFemalebusinessRenal carcinomaClear cellCalcificationBritish Journal of Urology
researchProduct